Shuxian Liu

ORCID: 0009-0009-0771-5782
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • CAR-T cell therapy research
  • Radiopharmaceutical Chemistry and Applications
  • RNA Interference and Gene Delivery
  • Curcumin's Biomedical Applications
  • Lymphoma Diagnosis and Treatment
  • Cell death mechanisms and regulation
  • Monoclonal and Polyclonal Antibodies Research

ZheJiang Institute For Food and Drug Control
2024

Hangzhou Normal University
2023

Bisdemethoxycurcumin (BDMC) is one of major forms curcuminoids found in the rhizomes turmeric. Docetaxel (DTX) standard care for men diagnosed with androgen-independent prostate cancers. Here we report first time that BDMC could reinforce effect DTX against cancer vitro and vivo. In study, PC3 LNCaP cells were cultured treated alone or combination. The effects on cell viability determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptosis was assessed...

10.1248/bpb.b24-00248 article EN Biological and Pharmaceutical Bulletin 2024-08-14

Abstract: Lymphoma is the eighth most common type of cancer worldwide. Currently, lymphoma mainly classified into two main groups: Hodgkin's (HL) and non-Hodgkin's (NHL), with NHL accounting for 80% to 90% cases. primarily divided B, T, natural killer (NK) cell lymphoma. Nanotechnology developing rapidly has made significant contributions field medicine. This review summarizes advancements nanobiotechnology in recent years its applications treatment NHL, especially diffuse large B (DLBCL),...

10.2174/1389557523666230915103121 article EN Mini-Reviews in Medicinal Chemistry 2023-09-19
Coming Soon ...